Armour Pharmaceutical published information about the current state of knowledge regarding non-A non-B Hepatitis. Read more about Armour Pharmaceutical published information about the current state of knowledge regarding non-A non-B Hepatitis.
Professor Zuckerman concluded that the use of blood concentrates should be restricted to life-threatening situations until blood donors could be screened for non-A non-B Hepatitis. Read more about Professor Zuckerman concluded that the use of blood concentrates should be restricted to life-threatening situations until blood donors could be screened for non-A non-B Hepatitis.
An article in The Lancet expressed concerns about the long-term consequences of non-A non-B Hepatitis. Read more about An article in The Lancet expressed concerns about the long-term consequences of non-A non-B Hepatitis.
Immuno considered that the British market would accept a higher risk of hepatitis for a lower-priced product. Read more about Immuno considered that the British market would accept a higher risk of hepatitis for a lower-priced product.
Professor Ingram asked Professor Charles Rizza to update the UKHCDO meeting minutes regarding the Immuno products. Read more about Professor Ingram asked Professor Charles Rizza to update the UKHCDO meeting minutes regarding the Immuno products.
It was raised at a UKHCDO meeting that Immuno would start selling Kryobulin Factor 8 concentrate at two prices. Read more about It was raised at a UKHCDO meeting that Immuno would start selling Kryobulin Factor 8 concentrate at two prices.
Dr Garrott Allen found that prison blood accounted for 90% of post-transfusion icteric hepatitis. Read more about Dr Garrott Allen found that prison blood accounted for 90% of post-transfusion icteric hepatitis.
Dr Rosemary Biggs predicted that within the next two years very large amounts of commercial products would become available in the US, and the UK would be obliged to purchase them at a high cost if it did not make urgent plans to meet its domestic demand. Read more about Dr Rosemary Biggs predicted that within the next two years very large amounts of commercial products would become available in the US, and the UK would be obliged to purchase them at a high cost if it did not make urgent plans to meet its domestic demand.
The NHS advisory report on testing for Hepatitis B described the methods available for detecting HBsAg and anti-HBs and recommended that CIE should no longer be used and that regional transfusion centres should use either reverse passive haemagglutination or radioimmunoassay. Read more about The NHS advisory report on testing for Hepatitis B described the methods available for detecting HBsAg and anti-HBs and recommended that CIE should no longer be used and that regional transfusion centres should use either reverse passive haemagglutination or radioimmunoassay.
A World Health Organization Scientific Group report on viral hepatitis stated that the present techniques for detecting Hepatitis B antigen were thought capable of preventing up to 30% of post-transfusion hepatitis, which were deemed more sensitive than earlier techniques. Read more about A World Health Organization Scientific Group report on viral hepatitis stated that the present techniques for detecting Hepatitis B antigen were thought capable of preventing up to 30% of post-transfusion hepatitis, which were deemed more sensitive than earlier techniques.